These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3247527)

  • 1. [Electrophysiologic effects of intravenous cibenzoline succinate, a new class I antiarrhythmic agent].
    Atarashi H; Iida K; Kou M; Hirayama Y; Gotoh M; Ino T; Katoh T; Hayakawa H
    Kokyu To Junkan; 1988 Oct; 36(10):1119-24. PubMed ID: 3247527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of cardiac rhythm disorders with pulsnorm].
    Zamotaev IP; Lozinskiĭ LG; Sandomirskiĭ BL
    Klin Med (Mosk); 1975 Jul; 53(7):57-61. PubMed ID: 1206994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of antistin in the treatment of arrhythmia].
    Cieśliński A
    Kardiol Pol; 1975; 18(2):121-8. PubMed ID: 1133885
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical evaluation of new antiarrhythmic agents: experiences with propafenone.
    Furlanello F; Disertori M; Vergara G; Guarnerio M; Dal Forno P; Padrini R; Gobbato S; Ferrari M
    Int J Clin Pharmacol Res; 1983; 3(2):101-5. PubMed ID: 6679511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a combination of class III and class Ic antiarrhythmic agents in patients with electrical storm.
    Fuchs T; Groysman R; Meilichov I
    Pharmacotherapy; 2008 Jan; 28(1):14-9. PubMed ID: 18154469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of the clinical study of a new anti-arrhythmia preparation allapinin].
    Mazur NA; Ivanova LA; Pavlova TS
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):30-3. PubMed ID: 3541962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy and electrophysiologic effects of cibenzoline therapy in patients with ventricular arrhythmias.
    Browne KF; Prystowsky EN; Zipes DP; Chilson DA; Heger JJ
    J Am Coll Cardiol; 1984 Mar; 3(3):857-64. PubMed ID: 6693656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H; Maison Blanche P; Marchand X; Canler A; Rouesnel P; Bleinc D; Péraudeau P; Scheck F
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cibenzoline. A review of its pharmacological properties and therapeutic potential in arrhythmias.
    Harron DW; Brogden RN; Faulds D; Fitton A
    Drugs; 1992 May; 43(5):734-59. PubMed ID: 1379150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hemodynamic effects of Norpace (Part I).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiarrhythmic effects of optical isomers of cibenzoline on canine ventricular arrhythmias.
    Haruno A; Matsuzaki T; Hashimoto K
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):376-82. PubMed ID: 1700207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-arrhythmic effect of dazolicin. Clinical-pharmacological research].
    Beck OA; Spielmann H; Witt E; Oeff M; Liddard C; Hochrein H
    Arzneimittelforschung; 1980; 30(12):2172-81. PubMed ID: 7194081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of bonnecor in ischemic heart disease].
    Gorshkov VA; Nesvetov VN; Chestukhin VV; Narynskiĭ AK; Kesarev GV; Solov'eva FV; Orlov VN; Ianitskaia MV; Solodukhina IS
    Sov Med; 1990; (6):72-4. PubMed ID: 2396129
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antazoline: the preferred drug for therapy of extra-systolic arrhythmia during anesthesia].
    Bottani G; Allaria B; Castelli S; Ferraris E
    Acta Anaesthesiol; 1968; 19(2):217-30. PubMed ID: 5757184
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of heart arrhythmia with phentolamine (preliminary report)].
    Maranhão MF; Lopes M; Rocha SW; Oliveira PF; Oliveira JC; Furlan L; Ramalho J; Romero Rojas RI; Carvalho RD; Loures DR; da Cunha GP
    Arq Bras Cardiol; 1976 Feb; 28(1):107-15. PubMed ID: 1259620
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and 4 properties, in patients with recurrent ventricular tachycardia.
    Cocco G; Strozzi C; Pansini R; Rochat N; Bulgarelli R; Padula A; Sfrisi C; Kamal Al Yassini A
    Eur Heart J; 1984 Feb; 5(2):108-14. PubMed ID: 6723683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic evaluation of intravenous bunaphtine in man.
    Di Biase M; Scarcia A; Chiddo A; Nacci E; Favale S; Rizzon P
    Acta Cardiol; 1977; 32(2):105-20. PubMed ID: 302072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.